- Trials with a EudraCT protocol (197)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
197 result(s) found for: Liver Dysfunction.
Displaying page 1 of 10.
EudraCT Number: 2005-001830-34 | Sponsor Protocol Number: 05LG12 | Start Date*: 2005-08-18 |
Sponsor Name:King's College Hospital | ||
Full Title: The use of Myfortic in paediatric patients after liver transplantation | ||
Medical condition: Liver transplantation | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-006023-33 | Sponsor Protocol Number: SIMFIB | Start Date*: 2021-10-26 | ||||||||||||||||
Sponsor Name:Institut d’Investigacions Biomèdiques August Pi i Sunyer | ||||||||||||||||||
Full Title: Efficacy of simvastatin reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled clinical trial. | ||||||||||||||||||
Medical condition: reduction of liver fibrosis in patients with advanced fibrosis due to alcohol | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005083-81 | Sponsor Protocol Number: ALBUCARD | Start Date*: 2006-06-09 |
Sponsor Name:HOSPITAL CLINIC | ||
Full Title: EFECTOS DE LA ADMINISTRACIÓN DE ALBÚMINA INTRAVENOSA SOBRE LA FUNCIÓN DIASTÓLICA DE LOS PACIENTES CON CIRROSIS HEPÁTICA. | ||
Medical condition: Liver cirrhosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001705-21 | Sponsor Protocol Number: 030705 | Start Date*: 2007-04-05 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO | |||||||||||||
Full Title: Phase II study to evaluate hepatic function and clinical aspects in patients with severe hepatic cirrhosis treated with multiple cycle of stem cells mobilisation by G-CSF administration. | |||||||||||||
Medical condition: Hepatic cirrhosis with severe liver dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002856-34 | Sponsor Protocol Number: LTx18-01 | Start Date*: 2019-03-01 | |||||||||||
Sponsor Name:Foundation for Liver research | |||||||||||||
Full Title: Modifying tacrolimus related toxicity after liver transplantation. A randomized controlled trial comparing Envarsus® and Advagraf® in de novo liver transplant recipients. | |||||||||||||
Medical condition: liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002416-27 | Sponsor Protocol Number: INFECIR2 | Start Date*: 2013-10-23 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Fundacio Clinic per a la recerca biomedica | ||||||||||||||||||||||||||||||||||||||
Full Title: Albumin administration in the prevention of hepatorenal syndrome and death in patients with cirrhosis, bacterial infections other than spontaneous bacterial peritonitis and high risk of hospital mo... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with advanced cirrhosis (serum creatinine > 1.2 mg/dl, serum sodium < 130 mEq/l and/or serum bilirubin > 4 mg/dl), signs of systemic inflammation and urinary infection, pneumonia, skin/sof... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: NO (Ongoing) ES (Ongoing) IT (Prematurely Ended) BE (Prematurely Ended) DE (Prematurely Ended) AT (Prematurely Ended) DK (Prematurely Ended) IE (Prematurely Ended) GB (Prematurely Ended) NL (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006234-34 | Sponsor Protocol Number: CD07/8396 | Start Date*: 2008-08-18 |
Sponsor Name:University of Leeds | ||
Full Title: 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: endothelial and endothelial progenitor cell function in men | ||
Medical condition: Objectives:To investigate whether statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) improve endothelial dysfunction in healthy volunteers (men). Endothelial dysfunction is an ear... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-004515-56 | Sponsor Protocol Number: hepatology_MT_2007-08 | Start Date*: 2008-04-28 |
Sponsor Name:Klinische Abteilung für Gastroenterologie und Hepatologie, Medizinische Universitätsklinik, MUG | ||
Full Title: Efficacy of ursodeoxycholic acid in the treatment of insulin resistance and vascular dysfunction in non-alcoholic fatty liver disease | ||
Medical condition: Non-alcoholic fatty liver disease (NAFLD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-008754-23 | Sponsor Protocol Number: CILT08 | Start Date*: 2009-12-16 | ||||||||||||||||||||||||||
Sponsor Name:University Medical Center Göttingen | ||||||||||||||||||||||||||||
Full Title: A Therapeutic Exploratory Study to Determine the Efficacy and Safety of Calcineurin-Inhibitor-Free de-novo Immunosuppression after Liver Transplantation. | ||||||||||||||||||||||||||||
Medical condition: Patients with renal dysfunction undergoing liver transplantation | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-002985-70 | Sponsor Protocol Number: MD-R20080507 | Start Date*: 2009-04-23 |
Sponsor Name:University of Magdeburg | ||
Full Title: Evaluation of the preventive effect of pentoxifylline and ursodeoxycholic acid to radiation induced liver toxicity after brachytherapy of liver metastases, assessed in a prospective randomised trial. | ||
Medical condition: Irradiation damage to the liver after HDR-brachytherapy of liver metastases. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000413-31 | Sponsor Protocol Number: 15871A | Start Date*: 2014-07-24 | ||||||||||||||||
Sponsor Name:H. Lundbeck A/S | ||||||||||||||||||
Full Title: Exploratory, interventional, open-label, fixed-dose study with Selincro® as-needed use, in alcohol dependent patients with liver impairment | ||||||||||||||||||
Medical condition: Alcohol dependence and liver impairment related to alcohol consumption | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-000152-19 | Sponsor Protocol Number: 1 | Start Date*: 2022-02-24 |
Sponsor Name:Consorcio Centro de Investigación Biomédica en Red, M.P. (CIBER) | ||
Full Title: Control strategies and pharmacogenetic study for the personalized treatment of fatty liver associated with metabolic dysfunction in patients with prediabetes. | ||
Medical condition: Metabolic Associated Fatty Liver Disease with prediabetes. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001581-20 | Sponsor Protocol Number: IRRB/72/14 | Start Date*: 2018-02-08 | |||||||||||||||||||||
Sponsor Name:ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE - ISMETT | |||||||||||||||||||||||
Full Title: THE ADDITION OF SIMVASTATIN ADMINISTRATION TO COLD STORAGE SOLUTION OF EXPLANTED WHOLE LIVER GRAFTS FOR FACING ISCHEMIA/REPERFUSION INJURY IN AN AREA WITH LOW RATE OF DECEASED DONATION. A MONOCENT... | |||||||||||||||||||||||
Medical condition: ISCHEMIC REPERFUSION INJURY AFTER LIVER TRANSPLANTATION: HEPATIC ISCHEMIA AND REPERFUSION INJURY REPRESENTS THE MAIN UNDERLYING MECHANISM FOR GRAFT DYSFUNCTION, AND FAILURE, POST-TRANSPLANTATION. H... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002597-41 | Sponsor Protocol Number: O321 | Start Date*: 2018-11-14 | |||||||||||
Sponsor Name:Adamed Pharma S.A. | |||||||||||||
Full Title: A multi-centre clinical trial evaluating patients’ ability to independently and safely use the medicinal product indicated in the treatment of erectile dysfunction | |||||||||||||
Medical condition: Erectile dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004031-23 | Sponsor Protocol Number: E2012AILIVER | Start Date*: 2014-08-26 | |||||||||||
Sponsor Name:Hopital Erasme | |||||||||||||
Full Title: Serum pharmacokinetics of Caspofungin in patients with liver failure. | |||||||||||||
Medical condition: The patient admitted for alcoholic hepatitis or decompensated cirrhosis (Child-Pugh score of 10-15) presenting with invasive aspergillosis (proven or probable) and treated by caspofungin. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002079-16 | Sponsor Protocol Number: E2013_PK_CASPO70_LIVERFAILURE | Start Date*: 2013-09-05 | |||||||||||
Sponsor Name:Hospital Erasme | |||||||||||||
Full Title: Pharmacokinetics of Caspofungin after one dose in patients with liver failure. | |||||||||||||
Medical condition: The pharmacokinetics parameters of caspofungin will be studied for the patient admitted for alcoholic hepatitis or decompensated cirrhosis (Child-Pugh score 7-15). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004663-22 | Sponsor Protocol Number: NRL972-05/2007 (ETOH) | Start Date*: 2008-04-14 | |||||||||||
Sponsor Name:Norgine Limited | |||||||||||||
Full Title: A multi-centre, open short term follow-up Phase II study to evaluate the clearance of NRL972 in patients undergoing alcohol withdrawal commencing in a controlled clinical setting. | |||||||||||||
Medical condition: Alcoholic liver disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002617-33 | Sponsor Protocol Number: VS01IIa01 | Start Date*: 2022-08-17 | |||||||||||
Sponsor Name:Versantis AG | |||||||||||||
Full Title: A Phase 2a, open-label, randomized, controlled, multi-center, proof of concept study, to assess the efficacy, safety and tolerability of VS-01 on top of standard of care, compared to standard of ca... | |||||||||||||
Medical condition: Acute-on-chronic liver failure (ACLF) is characterized by hepatic and extrahepatic organ dysfunction and/or failure and highly activated systemic inflammation. It leads to an accumulation of differ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004505-29 | Sponsor Protocol Number: 2676 | Start Date*: 2008-05-15 | |||||||||||
Sponsor Name:Royal Marsden NHS Trust | |||||||||||||
Full Title: Phase II clinical trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with previously untreated unresectable liver-only metastases from colorectal cancer | |||||||||||||
Medical condition: Metastatic colorectal adenocarcinoma with metastases involving the liver only | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022660-12 | Sponsor Protocol Number: PRAISE_ZKS0006 | Start Date*: 2011-02-02 | |||||||||||
Sponsor Name:Friedrich Schiller University | |||||||||||||
Full Title: A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantation | |||||||||||||
Medical condition: the early postoperative period after liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.